ResearcherShanghai Ninth People's HospitalNo recent work listed

Meng Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7641-2018; OpenAlex author ID A5100634631. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein Last author DOI 10.21203/rs.3.rs-3174433/v1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yiling Meng · 1 shared paper, 2023 · strength 0.18
- Paper Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein DOI 10.21203/rs.3.rs-3174433/v1 ↗
Guangbo Wu · 1 shared paper, 2023 · strength 0.18
- Paper Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein DOI 10.21203/rs.3.rs-3174433/v1 ↗
Dong Li · 1 shared paper, 2023 · strength 0.18
- Paper Metformin inhibits the growth of pancreatic cancer cells by inducing degradation of mutant p53 protein DOI 10.21203/rs.3.rs-3174433/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.